Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01369082 · ClinicalTrials.gov registry record

Extended Follow-Up After Islet Transplantation in T1D

A clinical trial of Type 1 Diabetes (T1D) and Islet Transplantation, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).

Completed
Registry status
75
Enrollment target
8
Study locations

NCT01369082 is a study of Type 1 Diabetes (T1D) and Islet Transplantation that has completed, run by National Institute of Allergy and Infectious Diseases (NIAID). The registered enrollment target is 75 participants, below the 176-participant average among 17 other Type 1 Diabetes (T1D) trials with a reported enrollment target (57% lower). The trial reports 8 study locations across 7 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01369082, a study of Type 1 Diabetes (T1D) and Islet Transplantation, has completed, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).

COMPLETED
Registry status
75 participants
Enrollment target
8
Study locations

Study Summary

The purpose of this study is to provide patients who have received at least one islet transplant as a previous participant in a Clinical Islet Transplantation Consortium (CIT) clinical trial with maintenance immunosuppressive medications and to collect information about the safety of the medications and islet function.

Conditions Studied

Type 1 Diabetes (T1D) Islet Transplantation

Interventions

  • DRUG Maintenance Immunosuppressive Treatment

Study Locations (8)

Illinois

  • Northwestern University - Chicago
  • University of Illinois - Chicago

California

  • University of California, San Francisco - San Francisco

Florida

  • University of Miami - Miami

Georgia

  • Emory University - Atlanta

Massachusetts

  • Massachusetts General Hospital - Boston

Minnesota

  • University of Minnesota - Minneapolis

Pennsylvania

  • University of Pennsylvania - Philadelphia

Trial Details

FieldValue
Enrollment Target 75 participants
Start Date 2011-05
Est. Completion 2017-07

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

2,006 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01369082

The ClinicalTrials.gov registry entry for NCT01369082 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 176-participant average among 17 other Type 1 Diabetes (T1D) trials with a reported enrollment target (57% lower). The listed sponsor is National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Type 1 Diabetes (T1D) appearing as the primary indexed condition, and to 1 intervention - of which Maintenance Immunosuppressive Treatment is the first listed.

NCT01369082 reports 8 study locations spanning 7 distinct geographic areas - top geographies include Illinois, California, Florida.

Frequently Asked Questions

What is clinical trial NCT01369082 about?

NCT01369082 is a clinical study titled "Extended Follow-Up After Islet Transplantation in T1D". The purpose of this study is to provide patients who have received at least one islet transplant as a previous participant in a Clinical Islet Transplantation Consortium (CIT) clinical trial with maintenance immunosuppressive medications and to collect information about the safety of the medications...

What is the current status of trial NCT01369082?

This trial is currently completed. The enrollment target is 75 participants. The study started on 2011-05. Estimated completion is 2017-07.

What conditions does trial NCT01369082 study?

This clinical trial studies the following conditions: Type 1 Diabetes (T1D), Islet Transplantation.

What interventions are being tested in trial NCT01369082?

The interventions under investigation include: Maintenance Immunosuppressive Treatment (DRUG).

Who is sponsoring clinical trial NCT01369082?

This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01369082 being conducted?

This trial has 8 study locations across California, Florida, Georgia, Illinois, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Type 1 Diabetes (T1D)

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Type 1 Diabetes (T1D)

All registered trials for this condition

Islet Transplantation

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.